Related references
Note: Only part of the references are listed.RNA-PROTACs: Degraders of RNA-Binding Proteins
Alice Ghidini et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Cancer Selective Target Degradation by Folate-Caged PROTACs
Jing Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras
Kusal T. G. Samarasinghe et al.
CELL CHEMICAL BIOLOGY (2021)
Advancing targeted protein degradation for cancer therapy
Brandon Dale et al.
NATURE REVIEWS CANCER (2021)
JASPAR 2020: update of the open-access database of transcription factor binding profiles
Oriol Fornes et al.
NUCLEIC ACIDS RESEARCH (2020)
PROTACs: A novel strategy for cancer therapy
Jing Liu et al.
SEMINARS IN CANCER BIOLOGY (2020)
Transcription Factor Inhibition: Lessons Learned and Emerging Targets
Andrew Chen et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Light-induced control of protein destruction by opto-PROTAC
Jing Liu et al.
SCIENCE ADVANCES (2020)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han et al.
CANCER CELL (2019)
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
Ning Wei et al.
ONCOGENE (2019)
Targeting transcription factors in cancer - from undruggable to reality
John H. Bushweller
NATURE REVIEWS CANCER (2019)
The Human Transcription Factors
Samuel A. Lambert et al.
CELL (2018)
Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer A Review
Miho Kono et al.
JAMA ONCOLOGY (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity
Matthew T. Weirauch et al.
CELL (2014)
Structure-Guided Design and Optimization of Small Molecules Targeting the Protein Protein Interaction between the von Hippel- Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities
Carles Galdeano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Prediction of DNA binding motifs from 3D models of transcription factors; identifying TLX3 regulated genes
Mario Pujato et al.
NUCLEIC ACIDS RESEARCH (2014)
DNA-Binding Specificities of Human Transcription Factors
Arttu Jolma et al.
CELL (2013)
STAT inhibitors for cancer therapy
Muhammad Furqan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Architecture of the human regulatory network derived from ENCODE data
Mark B. Gerstein et al.
NATURE (2012)
Photochemical Control of DNA Decoy Function Enables Precise Regulation of Nuclear Factor κB Activity
Jeane M. Govan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities
Michael F. Berger et al.
NATURE BIOTECHNOLOGY (2006)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1α complex
F Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
X-ray crystal structure of an IκBβ•NF-κB p65 homodimer complex
S Malek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Drug therapy: Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice
BL Riggs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
Endothelial healing in vein grafts Proliferative burst unimpaired by genetic therapy of neointimal disease
A Ehsan et al.
CIRCULATION (2002)
Share Paper
